Synthetic cannabinoid dependence, sustained partial remission

After a diagnosis of synthetic cannabinoid dependence, and often following a treatment episode or other intervention (including self-help intervention), there is a significant reduction in synthetic cannabinoid consumption for more than 12 months, such that even though synthetic cannabinoid use has occurred during this period, the definitional requirements for dependence have not been met.

ICD-11 diagnostic criteria

• wcześniej rozpoznane uzależnienie od syntetycznych kannabinoidów
• ograniczenie używania przez ponad 12 miesięcy

How to recognise

In the ICD-11 framework, the core symptoms taken into account when recognising Synthetic cannabinoid dependence, sustained partial remission are:

• historia uzależnienia od syntetycznych kannabinoidów

Differential diagnosis

When diagnosing Synthetic cannabinoid dependence, sustained partial remission, the following ICD-11 disorders should be considered in the differential diagnosis:

• Epizod szkodliwego używania syntetycznych kannabinoidów (6C42.0)
• Szkodliwy wzorzec używania syntetycznych kannabinoidów (6C42.1)

Frequently asked questions

How is Synthetic cannabinoid dependence, sustained partial remission diagnosed according to ICD-11?

According to ICD-11, the diagnostic criteria for Synthetic cannabinoid dependence, sustained partial remission (6C42.22) include: wcześniej rozpoznane uzależnienie od syntetycznych kannabinoidów; ograniczenie używania przez ponad 12 miesięcy.

What disorders are in the differential diagnosis of Synthetic cannabinoid dependence, sustained partial remission?

The differential diagnosis of Synthetic cannabinoid dependence, sustained partial remission (6C42.22) includes: Epizod szkodliwego używania syntetycznych kannabinoidów (6C42.0), Szkodliwy wzorzec używania syntetycznych kannabinoidów (6C42.1).

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C42.22 – WHO ICD-11